Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
Grant
Adjust height of sidebar
KMap
Grant
A Phase 1b/2a, Randomized, Double-Blind, Placebo Controlled, Multiple Ascending Dose Escalation Study of the Safety, Tolerability, and Efficacy of Intravenous AP-SA02 as an Adjunct to Best Available A
Sponsored by Armata Pharmaceuticals, Inc.
Active
$240.2K Funding
2 People
External
Related Topics
clinical trial,
drug safety,
intravenous therapy
People
Jose Elizondo
(CD)
Medicine
﹒Research Program Administration Officer III
Martha Barron
(CD)
Medicine
﹒Research Program Administration Officer III
